GlassScriptPhysician profile
Sami Al Kasab
NPI 1538509799
$10,530.37
in general payments reported to CMS, 2019-2025
10 companies · $1,111 in 2025
The $1,111 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,835 · 2020: $154 · 2021: $283 · 2022: $370 · 2023: $294 · 2024: $6,485 · 2025: $1,111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $2,426 · Travel and Lodging: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $2,426.03 |
| Travel and Lodging | $1,463.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,616.92 | 2022-2025 | Pipeline, Axium Primetm, Solitaire X |
| Stryker Corporation | $2,766.26 | 2019-2025 | Surpass Evolve, Target, Neuroform Atlas |
| Balt USA, LLC | $2,047.62 | 2024-2025 | Optima Coil System, Carrier Delivery Catheter |
| Depuy Synthes Sales INC. | $535.59 | 2022-2025 | Embotrap, N/A, Trufill |
| Penumbra, INC. | $294.38 | 2023-2024 | Red 72 |
| Siemens Medical Solutions USA, INC. | $117.44 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $58.11 | 2021-2022 | |
| Terumo Medical Corporation | $34.72 | 2022 | |
| Chiesi USA, INC. | $32.51 | 2024 | Kengreal, Cleviprex |
| Microvention, INC. | $26.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sami Al Kasab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.